BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29722546)

  • 1. EUPS-argues that lung cancer screening should be implemented in 18 months.
    Field JK; Baldwin DR; Devaraj A; Oudkerk M
    Br J Radiol; 2018 Oct; 91(1090):20180243. PubMed ID: 29722546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials.
    Silva M; Pastorino U; Sverzellati N
    Clin Radiol; 2017 May; 72(5):389-400. PubMed ID: 28168954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European position statement on lung cancer screening.
    Oudkerk M; Devaraj A; Vliegenthart R; Henzler T; Prosch H; Heussel CP; Bastarrika G; Sverzellati N; Mascalchi M; Delorme S; Baldwin DR; Callister ME; Becker N; Heuvelmans MA; Rzyman W; Infante MV; Pastorino U; Pedersen JH; Paci E; Duffy SW; de Koning H; Field JK
    Lancet Oncol; 2017 Dec; 18(12):e754-e766. PubMed ID: 29208441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of National Comprehensive Cancer Network and European Position Statement protocols for nodule management in low-dose computed tomography lung cancer screening in a general Chinese population.
    Du Y; Li Y; Dorrius MD; Sidorenkov G; Vonder M; Vliegenthart R; Heuvelmans MA; Cui X; Ye Z; de Bock GH
    J Thorac Dis; 2021 Dec; 13(12):6855-6865. PubMed ID: 35070370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on the European Lung Cancer Screening Trials and Comparison of Lung Cancer Screening Recommendations in Europe.
    Han D; Heuvelmans MA; Vliegenthart R; Rook M; Dorrius MD; Oudkerk M
    J Thorac Imaging; 2019 Jan; 34(1):65-71. PubMed ID: 30325795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose computed tomography lung cancer screening: Clinical evidence and implementation research.
    Lancaster HL; Heuvelmans MA; Oudkerk M
    J Intern Med; 2022 Jul; 292(1):68-80. PubMed ID: 35253286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT screening for lung cancer: Are we ready to implement in Europe?
    Balata H; Evison M; Sharman A; Crosbie P; Booton R
    Lung Cancer; 2019 Aug; 134():25-33. PubMed ID: 31319989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evidence for low-dose CT screening of lung cancer.
    Ruchalski K; Gutierrez A; Genshaft S; Abtin F; Suh R
    Clin Imaging; 2016; 40(2):288-95. PubMed ID: 26362352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer screening-low dose CT for lung cancer screening: recent trial results and next steps.
    O'Dowd EL; Baldwin DR
    Br J Radiol; 2018 Oct; 91(1090):20170460. PubMed ID: 28749712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung Cancer Screening: Computed Tomography Radiation and Protocols.
    Murugan VA; Kalra MK; Rehani M; Digumarthy SR
    J Thorac Imaging; 2015 Sep; 30(5):283-9. PubMed ID: 25856411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer screening: a critical appraisal.
    Kian W; Zemel M; Levitas D; Alguayn W; Remilah AA; Rahman NA; Peled N
    Curr Opin Oncol; 2022 Jan; 34(1):36-43. PubMed ID: 34652284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT screening for lung cancer: countdown to implementation.
    Field JK; Hansell DM; Duffy SW; Baldwin DR
    Lancet Oncol; 2013 Dec; 14(13):e591-600. PubMed ID: 24275132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pearls and Pitfalls in Lung Cancer CT Screening.
    Godoy MCB; Lago EAD; Pria HRFD; Shroff GS; Strange CD; Truong MT
    Semin Ultrasound CT MR; 2022 Jun; 43(3):246-256. PubMed ID: 35688535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose CT for lung cancer screening: opportunities and challenges.
    Shen H
    Front Med; 2018 Feb; 12(1):116-121. PubMed ID: 29218678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necessity of organized low-dose computed tomography screening for lung cancer: From epidemiologic comparisons between China and the Western nations.
    Gou HF; Liu Y; Yang TX; Zhou C; Chen XZ
    Oncotarget; 2017 Jan; 8(1):1788-1795. PubMed ID: 27705946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European and North American lung cancer screening experience and implications for pulmonary nodule management.
    Nair A; Hansell DM
    Eur Radiol; 2011 Dec; 21(12):2445-54. PubMed ID: 21830100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hesitancy around low-dose CT screening for lung cancer.
    Dickson JL; Horst C; Nair A; Tisi S; Prendecki R; Janes SM
    Ann Oncol; 2022 Jan; 33(1):34-41. PubMed ID: 34555501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.
    Field JK; Duffy SW; Baldwin DR; Whynes DK; Devaraj A; Brain KE; Eisen T; Gosney J; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rassl DM; Rintoul RC; Screaton NJ; Wald NJ; Weller D; Williamson PR; Yadegarfar G; Hansell DM
    Thorax; 2016 Feb; 71(2):161-70. PubMed ID: 26645413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.